Neglia C, Agnello N, Argentiero A, Chitano G, Quarta G, Bortone I, Della Rosa G, Caretto A, Distante A, Colao A, Di Somma C, Migliore A, Auriemma R S, Piscitelli P
Euro Mediterranean Biomedical Scientific Institute, Brindisi, Italy.
Department of Endocrinology, Local Health Authority, ASL Brindisi, Brindisi, Italy.
J Biol Regul Homeost Agents. 2014 Oct-Dec;28(4):733-41.
Type 2 diabetes mellitus (T2DM) is associated with a higher risk of fractures even in presence of normal or increased bone mineral density. The purpose of this three-year longitudinal study was to evaluate the risk of osteoporotic fractures by assessing the changes of Quantitative Ultrasound (QUS) parameters in a group of postmenopausal women with type 2 diabetes mellitus (T2DM) compared with non-diabetic controls. The measurements were taken on a group of 18 postmenopausal women affected by T2DM and 18 healthy age-matched controls, aged 55-70 years, referring to the Osteolab laboratory at the ISBEM Research Institute (Brindisi, Italy) between 2009 and 2013. Subjects had baseline and 3-year follow-up measurements with phalangeal QUS carried out by a DBM Sonic Bone Profiler 1200 (Igea®); medical history, current drug therapies and risk factors for fractures were recorded for each patient. The analyzed phalangeal QUS parameters were Amplitude-Dependent Speed of Sound (AD-SoS), Bone Transmission Time (BTT), Fast Wave Amplitude (FWA) and Signal Dynamic (SDy). At the baseline visit we found no statistically significant difference between T2DM and non-diabetic patients when looking at phalangeal QUS parameters. At the three-year follow-up visit, a significantly higher decrease of both BTT (P<0.001) and AD-SoS (P<0.001) parameters was found in the T2DM group. On the contrary, the decrease of FWA was significantly higher in non-diabetic controls (P<0.001). Our data confirm the ability of phalangeal QUS to detect differences in the risk of osteoporotic fractures in T2DM postmenopausal women compared to non-diabetic controls. The study suggests that T2DM women present a higher cortical porosity and increased trabecular bone density compared to non-diabetic controls, respectively shown by the higher decrease of both AD-SoS and BTT and the lower decrease of FWA.
2型糖尿病(T2DM)即便在骨矿物质密度正常或增加的情况下,骨折风险也更高。这项为期三年的纵向研究旨在通过评估一组绝经后2型糖尿病(T2DM)女性与非糖尿病对照者的定量超声(QUS)参数变化,来评估骨质疏松性骨折的风险。测量对象为18名受T2DM影响的绝经后女性和18名年龄匹配的健康对照者,年龄在55至70岁之间,于2009年至2013年间前往意大利布林迪西ISBEM研究所的Osteolab实验室。受试者接受了由DBM Sonic Bone Profiler 1200(Igea®)进行的指骨QUS基线测量和3年随访测量;记录了每位患者的病史、当前药物治疗情况和骨折风险因素。分析的指骨QUS参数包括振幅依赖声速(AD-SoS)、骨传导时间(BTT)、快波振幅(FWA)和信号动态(SDy)。在基线访视时,观察指骨QUS参数,T2DM患者与非糖尿病患者之间无统计学显著差异。在三年随访访视时,T2DM组的BTT(P<0.001)和AD-SoS(P<0.001)参数下降幅度显著更高。相反,非糖尿病对照组的FWA下降幅度显著更高(P<0.001)。我们的数据证实了指骨QUS能够检测出T2DM绝经后女性与非糖尿病对照者在骨质疏松性骨折风险方面的差异。该研究表明,与非糖尿病对照者相比,T2DM女性分别表现出更高的皮质孔隙率和增加的小梁骨密度,这分别通过AD-SoS和BTT的更高下降幅度以及FWA的更低下降幅度得以体现。